A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

Clinical trial NCT05453578 · COMPLETED

Trial details

NCT number: NCT05453578
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bacterial Disease Carrier Cystic Fibrosis

Start date: 2022-10-03
Primary completion: 2025-04-10
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.